Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Novel procedure with improved resolution and specificity for amplification and differentiation of variants of the gene encoding carboxylesterase 1

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Re: The recent paper 'Genetic determinants of impaired awareness of hypoglycaemia in type 1 diabetes'

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Nomenclature for alleles of the human carboxylesterase 1 gene

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  3. Patients with prolonged effect of succinylcholine or mivacurium had novel mutations in the butyrylcholinesterase gene

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Are All Psychotic-Like Experiences Really "Psychotic"? Response to McLawhorn and Jackson

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Somatiske årsager til akut opståede psykiatriske tilstande hos børn og unge

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Pulmonary administration of remdesivir in the treatment of COVID-19

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Birth with Synthetic Oxytocin and Risk of Childhood Emotional Disorders: A Danish Population-based Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Carboxylesterase 1 (CES1) is implicated in the metabolism of several commonly used drugs and other xenobiotics. The gene encoding this enzyme, CES1, is duplicated in some individuals. The original gene copy is called CES1A1. The duplicated version, CES1A2, is a hybrid of CES1A1 and the CES1-related pseudogene, CES1P1. Variants of CES1A2 with a weak and a strong promoter, respectively, have been reported. In addition, there are chimeric subtypes of CES1A1 that contain a segment of CES1P1. Collectively, this represents challenges to the genotyping of CES1 that previous procedures have had difficulties in solving, frequently leading to loss of specificity and inaccurate genotyping. Here, we report a novel and specific procedure that can selectively amplify CES1A1 and CES1A2 and accurately determine their variants. This procedure may be useful for personalization of treatments with drugs metabolized by CES1.

OriginalsprogEngelsk
TidsskriftPharmacogenetics and Genomics
Vol/bind27
Udgave nummer4
Sider (fra-til)155-158
Antal sider4
ISSN1744-6872
DOI
StatusUdgivet - apr. 2017

ID: 51762484